je.st
news
India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
2013-03-18 16:20:28| Biotech - Topix.net
India's BDR Pharmaceuticals International Pvt Ltd has applied to the Indian patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, dasatinib, through a so-called compulsory licence mechanism, a BDR executive said on Monday.
Tags: version
sell
drug
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||